Ellinor I.B. Peerschke

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

51h-index9.7kcitations209works8.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Platelet Disorders and Treatments(76), Complement system in diseases(52), Coagulation, Bradykinin, Polyphosphates, and Angioedema(41), Monoclonal and Polyclonal Antibodies Research(32), Blood properties and coagulation(26)

Publications208 total

The C1q and gC1qR axis as a novel checkpoint inhibitor in cancer
Frontiers in Immunology·2024· 12 citedOpen Access
Author Correction: Senolytic CAR T cells reverse senescence-associated pathologies
Nature·2024· 5 citedOpen Access
Analytical Validation and Performance Characteristics of Molecular Serum Biomarkers, miR-371a-3p and miR-372-3p, for Male Germ Cell Tumors, in a Clinical Laboratory Setting
Journal of Molecular Diagnostics·2022· 16 citedOpen Access
Ischemic stroke with cancer: Hematologic and embolic biomarkers and clinical outcomes
Journal of Thrombosis and Haemostasis·2022· 32 citedOpen Access
Abstract WP198: Hematological And Embolic Biomarkers And Clinical Outcomes In Patients With Cancer And Ischemic Stroke
Stroke·2022
SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems
Frontiers in Immunology·2021· 49 citedOpen Access
Heritable platelet disorders: an enigma even guidelines can’t unravel
British Journal of Haematology·2021Open Access
Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19
Frontiers in Immunology·2021· 12 citedOpen Access
Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective Study
Annals of Neurology·2021· 68 citedOpen Access
Heterozygous P32/C1QBP/HABP1 Polymorphism rs56014026 Reduces Mitochondrial Oxidative Phosphorylation and Is Expressed in Low-grade Colorectal Carcinomas
Frontiers in Oncology·2021· 15 citedOpen Access
Loss of Mucosal p32/gC1qR/HABP1 Triggers Energy Deficiency and Impairs Goblet Cell Differentiation in Ulcerative Colitis
Cellular and Molecular Gastroenterology and Hepatology·2021· 51 citedOpen Access
Loss of p32 triggers energy deficiency and impairs goblet cell differentiation in ulcerative colitis
2020· 1 citedOpen Access
Choosing wisely during the COVID-19 pandemic: optimising outpatient cancer care while conserving resources with a new algorithm to report automated ANC results
Journal of Clinical Pathology·2020Open Access
SLE: Novel Postulates for Therapeutic Options
Frontiers in Immunology·2020· 9 citedOpen Access
Anti gC1qR/p32/HABP1 Antibody Therapy Decreases Tumor Growth in an Orthotopic Murine Xenotransplant Model of Triple Negative Breast Cancer
Antibodies·2020· 7 citedOpen Access
Complement and coagulation: key triggers of COVID-19–induced multiorgan pathology
Journal of Clinical Investigation·2020· 45 citedOpen Access
gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma
Frontiers in Oncology·2020· 24 citedOpen Access
Senolytic CAR T cells reverse senescence-associated pathologies
Nature·2020· 972 citedOpen Access
Developing Quality Programs for Cell-Free DNA (cfDNA) Extraction from Peripheral Blood
The Journal of Applied Laboratory Medicine·2020· 8 citedOpen Access
Choosing Wisely: Optimizing Outpatient Cancer Care and Conserving Resources with a New Algorithm to Report Automated ANC Results in the Presence of Analyzer Flags
Blood·2019
page 1 of 11Next →

Frequent Co-authors

Berhane Ghebrehiwet(29), K.B.M. Reid(6), Boon Leong Lim(4), Wei Yin(3), Kinga Hosszu(3), Berhane Ghebrehiwet(3), Mitchell S.V. Elkind(3), Donna D. Castellone(3), Phoebe D. Lu(3), Jennifer Frontera(2), John J. Lewin(2), Alejandro A. Rabinstein(2), Imo Aisiku(2), Anne W. Alexandrov(2), Aaron M. Cook(2), Gregory J. del Zoppo(2), Monisha A. Kumar(2), Michael Stiefel(2), Jeanne Teitelbaum(2), Katja E. Wartenberg(2)